| pubmed-article:16794987 | pubmed:abstractText | To date, various and partly competitive screening strategies for the risk calculation of trisomy 21 are applied in Germany. The aim of this study was to control the published test performance data of different methods in an unselected group of patients, thus allowing us to clearly assess the practical value of the respective methods. | lld:pubmed |
